Pirfenidone Combined With Standard First-Line Chemotherapy in Advanced-Stage Lung NSCLC
H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
Mayo Clinic
BeiGene
University Health Network, Toronto
University Hospital, Limoges
EpicentRx, Inc.
Novartis
Novartis
BeiGene
Cantargia AB
Eisai Inc.
Barbara Ann Karmanos Cancer Institute
Intergroupe Francophone de Cancerologie Thoracique
Innovent Biologics (Suzhou) Co. Ltd.
SCRI Development Innovations, LLC
SCRI Development Innovations, LLC
Chonnam National University Hospital
Swiss Cancer Institute
BioNTech SE
Novartis
Massachusetts General Hospital
Dutch Society of Physicians for Pulmonology and Tuberculosis
Mereo BioPharma
University of Maryland, Baltimore
Eli Lilly and Company
Eli Lilly and Company
Northwestern University
Swiss Cancer Institute
M.D. Anderson Cancer Center
Mayo Clinic
Shanghai University of Traditional Chinese Medicine
University of California, Davis
Memorial Sloan Kettering Cancer Center
EMD Serono
Memorial Sloan Kettering Cancer Center
Masonic Cancer Center, University of Minnesota
UNC Lineberger Comprehensive Cancer Center
Roswell Park Cancer Institute
University of Washington
H. Lee Moffitt Cancer Center and Research Institute
Alliance for Clinical Trials in Oncology
Stanford University
M.D. Anderson Cancer Center
Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology
Sanofi
Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology
Martha-Maria Krankenhaus Halle-Dölau gGmbH